X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.cnbctv18.com/healthcare/zydus-lifesciences-gets-final-approval-from-the-us-fda-to-market-estradiol-transdermal-system-16431761.htm
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2023-25079.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-elagolix-sodium-estradiol-norethindrone-acetate-capsules-71055.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206241
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211783
https://www.fiercepharma.com/pharma/myovant-pfizers-myfembree-wins-fda-nod-endometriosis
https://www.fiercepharma.com/pharma/pfizer-myovants-myfembree-back-track-endometriosis-nod-aug-execs-say
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fagron-group-bv-624255-06142022
https://www.pharmatimes.com/news/nice_draft_final_guidance_for_gedeon_richter_uks_new_uterine_fibroids_treatment_1448342
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf
http://www.pharmafile.com/news/588612/theramex-pioneers-new-treatment-post-menopausal-women
https://www.prnewswire.com/news-releases/avion-pharmaceuticals-recognizes-menopause-awareness-month-by-announcing-the-addition-of-divigel-estradiol-gel-0-1-to-their-product-portfolio-301379678.html
https://www.globenewswire.com/news-release/2021/09/09/2294109/0/en/Myovant-Sciences-and-Pfizer-Announce-FDA-Acceptance-of-Supplemental-New-Drug-Application-for-MYFEMBREE-for-the-Management-of-Moderate-to-Severe-Pain-Associated-With-Endometriosis.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.ema.europa.eu/en/documents/overview/ryeqo-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2021/06/28/2253818/30757/en/Dar%C3%A9-Bioscience-Announces-Positive-Phase-1-Results-for-DARE-HRT1.html
https://extranet.who.int/prequal/news/bayer-estradiolnorethisterone-injection-pre-filled-syringes-prequalified
https://www.prnewswire.com/news-releases/sumitovant-biopharma-announces-publication-of-myovant-abstracts-detailing-additional-efficacy-and-safety-findings-from-phase-3-liberty-studies-in-uterine-fibroids-in-obstetrics--gynecology-301049697.html
https://www.prnewswire.com/news-releases/sumitovant-biopharma-reports-key-clinical-and-regulatory-milestones-by-myovant-sciences-301046868.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-22-2020-1587564893.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-bijuva-nda-210132-estradiol-and-progesterone-4-mcg-and-10-mcg-1585974134.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-imvexxy-208564-estradiol-4-mcg-and-10-mcg-1582965685.pdf
https://www.ema.europa.eu/en/news/four-week-limit-use-high-strength-estradiol-creams
https://seekingalpha.com/news/3522041-health-canada-review-knights-nds-bijuva
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-recalls-over-2-lakh-cartons-of-product-in-us/articleshow/71991476.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-6-2019-1573017375.pdf
https://www.businesswire.com/news/home/20191030005762/en/Knight-TherapeuticsMD-Announce-Filing-New-Drug-Submission/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.ema.europa.eu/en/news/four-week-limit-use-high-strength-estradiol-creams
https://www.ema.europa.eu/en/news/four-week-limit-use-high-strength-estradiol-creams
https://en.prnasia.com/releases/global/mayne-pharma-signs-20-year-exclusive-license-and-supply-agreement-for-novel-oral-contraceptive-in-the-us-259662.shtml
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-7-2019-1565155577.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202318
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2019-1560925761.pdf
Market Place
Share 
